Biotech & Life Sciences startups and investors we cover
Shortlist companies and funds tagged Biotech & Life Sciences in our directory. This hub is a sector cut, not a complete market census. Search every startup from /startups or open the investor list.
Startups in this sector
Showing 12 of 100 matched profiles.
-
Astromech
Colossal spinout building predictive models of biology using evolutionary and genomic data.
-
Boltz
MIT-founded biotech applying open AI protein models to lab deployment (public-benefit corp).
-
Adaptyv
YC S21 automated wet lab that synthesizes and tests AI-designed proteins and returns experimental data.
-
AusperBio
Clinical-stage oligonucleotide company developing ASO and targeted-siRNA candidates aimed at a functional cure for chronic hepatitis B.
-
Anagram Therapeutics
Clinical-stage biotech developing non-porcine oral enzyme therapies to replace 15–40 daily pills for pancreatic insufficiency.
-
Aureka Biotechnologies
AI-native TechBio building biological foundation models with closed-loop wet-lab infrastructure.
-
Pearl Diagnostics
Johns Hopkins spinout commercializing noninvasive urine assays for lung infections (Aspergillus, Pseudomonas).
-
Neurava
Baltimore medtech building wearable monitoring for epilepsy seizures and SUDEP risk stratification.
-
Inner Logic
Simulation and testing platform for surgical and procedural medical devices — Hopkins-founded.
-
Biome Makers
Soil microbiome analytics platform (BeCrop) for farmers, agronomists, and input manufacturers.
-
Bayesian Health
Clinical AI platform for real-time patient risk stratification and triage in hospitals.
-
TIXiMED
UAB spinout developing TIX100, an oral TXNIP inhibitor for Type 1 diabetes.
Investors in this sector
Showing 12 of 43 matched funds.
-
ARCH Venture Partners
Chicago-based life-sciences specialist that co-founds and funds seed through growth-stage biotech and deep-science companies, often originating companies directly from academic research.
-
Arboretum Ventures
Ann Arbor healthcare VC founded 2002. Manages ~$1B across six funds; Fund VI closed at $268M (June 2023). Focus: medical devices, life science tools & diagnostics, tech-enabled care, pharma adjacencies — with preference for under-ventured geographies including the Midwest. Main office: First National Building, 201 S. Main Street, Suite 300, Ann Arbor, MI 48104.
-
Atlas Venture
Cambridge, MA–based biotech venture firm that creates and builds early-stage life-sciences companies, partnering with scientists from company formation through Series A.
-
BioGenerator Ventures
St. Louis company-creation and early-stage investor focused on healthcare and agriculture. Part of the BioSTL ecosystem; BioGenerator dates to 2003 as a regional life-science formation engine. BioGenerator Ventures builds companies from concepts/EIRs, invests from an evergreen model, and syndicates with national venture and strategic capital. Sectors: therapeutics, diagnostics, research tools, and agtech. HQ St. Louis, MO.
-
Buffalo Innovation Seed Fund
$10M evergreen early-stage fund affiliated with University at Buffalo Startup Ventures; capitalized via New York State ESD Innovation Hub and the SUNY Research Foundation. Cultivator investments up to $100k; Seed investments up to $250k with a 1:1 match requirement to non-NYS funds.
-
Chrysalis Ventures
Louisville-based venture firm investing in healthcare and technology companies across the Midwest and South. Long-running Kentucky institutional VC presence.
-
CincyTech
Cincinnati seed-stage firm and one of the Midwest’s most active seed investors, supported by Ohio Third Frontier and founding partners including Cincinnati Children’s, University of Cincinnati, and the Cincinnati USA Regional Chamber. Address: 2900 Reading Rd. Ste. 410, Cincinnati, OH 45206.
-
Clarevia Ventures
Midwest healthcare VC formerly Venture Investors Health Fund (founded 1984). ~$350M AUM. Madison HQ at University Research Park (510 Charmany Drive, Suite 250, Madison, WI 53719) with Ann Arbor and Milwaukee offices. Early-stage medtech and life sciences.
-
Cottonwood Technology Fund
Southwest deep-tech venture firm (founded 2010) investing in patent-based hard science at pre-seed and seed — photonics, advanced materials, nanotechnology, robotics, medical technology, and climate hardware. Offices in Santa Fe, Denver, and the Netherlands; Fund IV first close March 2025 targeting $80M.
-
Cultivation Capital
St. Louis early-stage venture firm founded in 2012. Manages a family of funds focused on seed and Series A across life sciences/health tech, software & IT, agriculture tech, and geospatial tech. Initial checks publicly described in the $100k–$3.5M range; the firm says it leads about half the rounds it joins. HQ at 911 Washington Ave, Suite 801, St. Louis, MO.
-
DeepWork Capital
Orlando early-stage VC (founded 2015; formerly FAN Fund) investing Seed and Series A in technology and life sciences, primarily in Florida and other undercapitalized U.S. regions. Office: 1000 Legion Place, Suite 830, Orlando, FL 32801.
-
Desert Angels
Tucson-based nonprofit angel network of accredited investors. Founded 2000; members report $62.5M+ invested into 165+ companies and sidecar SPVs. Accepts preferred equity or convertible notes (not SAFEs) for North American early-stage companies; monthly screening via Dealum.